These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 8160825)

  • 1. Platelet-activating factor modulates microvascular transport by stimulation of protein kinase C.
    Kobayashi I; Kim D; Hobson RW; Durán WN
    Am J Physiol; 1994 Mar; 266(3 Pt 2):H1214-20. PubMed ID: 8160825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet-activating factor modulates microvascular dynamics through phospholipase C in the hamster cheek pouch.
    Kim DD; Ramírez MM; Durán WN
    Microvasc Res; 2000 Jan; 59(1):7-13. PubMed ID: 10625566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet-activating factor stimulates protein tyrosine kinase in hamster cheek pouch microcirculation.
    Kim D; Durán WN
    Am J Physiol; 1995 Jan; 268(1 Pt 2):H399-403. PubMed ID: 7530921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet activating factor modulates microvascular permeability through nitric oxide synthesis.
    Ramírez MM; Quardt SM; Kim D; Oshiro H; Minnicozzi M; Durán WN
    Microvasc Res; 1995 Sep; 50(2):223-34. PubMed ID: 8538502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of platelet-activating factor on microvascular permselectivity: dose-response relations and pathways of action in the hamster cheek pouch microcirculation.
    Dillon PK; Durán WN
    Circ Res; 1988 Apr; 62(4):732-40. PubMed ID: 2450695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistance and exchange microvessels are modulated by different PAF receptors.
    Tomeo AC; Durán WN
    Am J Physiol; 1991 Nov; 261(5 Pt 2):H1648-52. PubMed ID: 1659229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasoconstrictor effects of platelet-activating factor in the hamster cheek pouch microcirculation: dose-related relations and pathways of action.
    Dillon PK; Ritter AB; Durán WN
    Circ Res; 1988 Apr; 62(4):722-31. PubMed ID: 2832096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein kinase C modulates microvascular permeability through nitric oxide synthase.
    Ramírez MM; Kim DD; Durán WN
    Am J Physiol; 1996 Oct; 271(4 Pt 2):H1702-5. PubMed ID: 8897966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. L-type calcium channel blockers modulate the microvascular hyperpermeability induced by platelet-activating factor in vivo.
    Oshiro H; Kobayashi I; Kim D; Takenaka H; Hobson RW; Durán WN
    J Vasc Surg; 1995 Dec; 22(6):732-9; discussion 739-41. PubMed ID: 8523608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapamycin inhibits VEGF-induced microvascular hyperpermeability in vivo.
    Kim DD; Kleinman DM; Kanetaka T; Gerritsen ME; Nivaggioli T; Weber D; Durán WN
    Microcirculation; 2010 Feb; 17(2):128-36. PubMed ID: 20163539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of nitric oxide synthase attenuates primed microvascular permeability in the in vivo microcirculation.
    Noel AA; Fallek SR; Hobson RW; Durán WN
    J Vasc Surg; 1995 Dec; 22(6):661-9; discussion 669-70. PubMed ID: 8523600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet-activating factor induces airway mucin release via activation of protein kinase C: evidence for translocation of protein kinase C to membranes.
    Larivée P; Levine SJ; Martinez A; Wu T; Logun C; Shelhamer JH
    Am J Respir Cell Mol Biol; 1994 Aug; 11(2):199-205. PubMed ID: 8049080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute microcirculatory effects of platelet-activating factor.
    Durán WN; Dillon PK
    J Lipid Mediat; 1990; 2 Suppl():S215-27. PubMed ID: 2133284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein kinase C inhibition enhances platelet-activating factor-induced eicosanoid production in human eosinophils.
    Dent G; Muñoz NM; Rühlmann E; Zhu X; Leff AR; Magnussen H; Rabe KF
    Am J Respir Cell Mol Biol; 1998 Jan; 18(1):136-44. PubMed ID: 9448055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obligatory role of nitric oxide in platelet-activating factor-induced microvascular leakage.
    Klabunde RE; Anderson DE
    Eur J Pharmacol; 2000 Sep; 404(3):387-94. PubMed ID: 10996604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute microvascular effects of PAF-acether, as studied by intravital microscopy.
    Björk J; Smedegård G
    Eur J Pharmacol; 1983 Dec; 96(1-2):87-94. PubMed ID: 6662199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implication of protein kinase C alpha in PAF-stimulated phospholipase D activation in Chinese hamster ovary (CHO) cells expressing PAF receptor.
    Liu B; Nakashima S; Takano T; Shimizu T; Nozawa Y
    Biochem Biophys Res Commun; 1995 Sep; 214(2):418-23. PubMed ID: 7677747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet-activating factor and nitric oxide mediate microvascular permeability in ischemia-reperfusion injury.
    Noel AA; Hobson RW; Durán WN
    Microvasc Res; 1996 Nov; 52(3):210-20. PubMed ID: 8954863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Priming interactions between platelet activating factor and histamine in the in vivo microcirculation.
    Tomeo AC; Egan RW; Durán WN
    FASEB J; 1991 Oct; 5(13):2850-5. PubMed ID: 1655549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of platelet-activating factor on arteriolar and venular tone in rat trachea.
    Collins LC; Roberts AM
    Microvasc Res; 1997 Jan; 53(1):63-72. PubMed ID: 9056476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.